Yihai Cao
Impact in
- Cancer Research top 0.05%
- Cancer, Hypoxia, and Metabolism
- Protease and Inhibitor Mechanisms
- Oncology top 0.1%
- Lymphatic System and Diseases
- Cancer Cells and Metastasis
Papers in
-
- Angiogenesis and VEGF in Cancer 124
- Fibroblast Growth Factor Research 23
-
- Cancer, Hypoxia, and Metabolism 64
- Protease and Inhibitor Mechanisms 15
- Co-authors
- Renhai Cao (62 shared papers)Ebba Bråkenhielm (17 shared papers)Takahiro Seki (23 shared papers)Yunlong Yang (40 shared papers)Sharon Lim (27 shared papers)Kari Alitalo (6 shared papers)Henrich Cheng (1 shared paper)Kayoko Hosaka (34 shared papers)
- Journals
- Proceedings of the National Academy of Sciences (44 papers)Cancer Research (9 papers)Nature Communications (9 papers)Advanced Science (8 papers)The FASEB Journal (5 papers)
- Partner nations
- SwedenChinaUnited States
In The Last Decade
Yihai Cao
284 papers receiving 29.6k citations
Yihai Cao's Hit Papers
Peers
Comparison fields: 5 of 180
- Cancer Research 6.1k
- Oncology 6.5k
- Molecular Biology 15.1k
- Immunology and Allergy 1.2k
- Developmental Neuroscience 666
Countries citing papers authored by Yihai Cao
This map shows the geographic impact of Yihai Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yihai Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yihai Cao more than expected).
Fields of papers citing papers by Yihai Cao
This network shows the impact of papers produced by Yihai Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yihai Cao. The network helps show where Yihai Cao may publish in the future.
Co-authors
The 25 scholars most cited alongside Yihai Cao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 287 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Monitoring Drug Target Engagement in Cells and Tissues Using the Cellular Thermal Shift Assay Hit paper breakdown → | 2013 | 1616 |
| 2 | Novel concept of the smart NIR-light–controlled drug release of black phosphorus nanostructure for cancer therapy Hit paper breakdown → | 2018 | 753 |
| 3 | Impaired endochondral ossification and angiogenesis in mice deficient in membrane-type matrix metalloproteinase I Hit paper breakdown → | 2000 | 693 |
| 4 | Spinal Cord Repair in Adult Paraplegic Rats: Partial Restoration of Hind Limb Function Hit paper breakdown → | 1996 | 670 |
| 5 | Proteolytic processing regulates receptor specificity and activity of VEGF‐C Hit paper breakdown → | 1997 | 651 |
| 6 | Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis Hit paper breakdown → | 2004 | 628 |
| 7 | Angiogenic synergism, vascular stability and improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2 Hit paper breakdown → | 2003 | 615 |
| 8 | Angiogenesis modulates adipogenesis and obesity Hit paper breakdown → | 2007 | 597 |
| 9 | Inhibitory PAS domain protein is a negative regulator of hypoxia-inducible gene expression Hit paper breakdown → | 2001 | 562 |
| 10 | Vascular endothelial growth factor C induces angiogenesis in vivo Hit paper breakdown → | 1998 | 501 |
| 11 | 2004 | 440 | |
| 12 | 1997 | 427 | |
| 13 | Macrophage-targeted nanomedicine for the diagnosis and treatment of atherosclerosis Hit paper breakdown → | 2021 | 398 |
| 14 | 2001 | 390 | |
| 15 | The landscape of mRNA nanomedicine Hit paper breakdown → | 2022 | 389 |
| 16 | Adipocyte and lipid metabolism in cancer drug resistance Hit paper breakdown → | 2019 | 371 |
| 17 | 2010 | 353 | |
| 18 | 1996 | 326 | |
| 19 | In situ sprayed NIR-responsive, analgesic black phosphorus-based gel for diabetic ulcer treatment Hit paper breakdown → | 2020 | 321 |
| 20 | 2009 | 313 |
About Yihai Cao
Yihai Cao is a scholar working on Molecular Biology, Cancer Research, Oncology, Cell Biology and Physiology, having authored 287 papers that have together received 30.3k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (124 papers), Cancer, Hypoxia, and Metabolism (64 papers), Lymphatic System and Diseases (30 papers), Adipose Tissue and Metabolism (26 papers), Fibroblast Growth Factor Research (23 papers), Adipokines, Inflammation, and Metabolic Diseases (20 papers), Zebrafish Biomedical Research Applications (16 papers) and Protease and Inhibitor Mechanisms (15 papers). The work is most often cited by research in Cancer Research (6.1k citations), Oncology (6.5k citations), Molecular Biology (15.1k citations), Immunology and Allergy (1.2k citations) and Developmental Neuroscience (666 citations). Yihai Cao has collaborated with scholars based in Sweden, China and United States. Frequent co-authors include Renhai Cao, Ebba Bråkenhielm, Takahiro Seki, Yunlong Yang, Sharon Lim, Kari Alitalo, Henrich Cheng, Kayoko Hosaka, Róbert Langer and Lasse D. Jensen. Their work appears in journals such as Proceedings of the National Academy of Sciences, Cancer Research, Nature Communications, Advanced Science and The FASEB Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.